SUBSCRIBE
SUBSCRIBE

Apellis Pharmaceuticals Inc

NEWS
Amneal and Impax to Marry, Creating the 5th Larges
Deals
Cancer Biotech Apellis Pharma Sets Terms for $150M IPO
The Crestwood, KY-based company plans to raise $150M by offering 10.7 million shares at a price range of $13 to $15.
October 31, 2017
 · 
1 min read
Load More
JOBS
IN THE PRESS
Genetown
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 04, 2024
April 4, 2024
 · 
2 min read
Genetown
Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
April 1, 2024
 · 
1 min read
Business
Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
March 11, 2024
 · 
5 min read
Genetown
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 06, 2024
March 6, 2024
 · 
2 min read
Business
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
 · 
23 min read
Genetown
Apellis Pharmaceuticals to Present at Upcoming March 2024 Investor Conferences
February 26, 2024
 · 
1 min read
Business
Apellis Pharmaceuticals to Host Conference Call on February 27, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results
February 20, 2024
 · 
1 min read
Genetown
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 06, 2024
February 6, 2024
 · 
2 min read
Genetown
Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application
January 26, 2024
 · 
5 min read
Business
Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U.S. Net Product Revenues
January 8, 2024
 · 
12 min read
Load More